These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36446486)

  • 21. Sulfobutylether-β-cyclodextrin/5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphine nanoassemblies with sustained antimicrobial phototherapeutic action.
    Zagami R; Franco D; Pipkin JD; Antle V; De Plano L; Patanè S; Guglielmino S; Monsù Scolaro L; Mazzaglia A
    Int J Pharm; 2020 Jul; 585():119487. PubMed ID: 32492506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver nanoparticles based on sulfobutylether-β-cyclodextrin functionalized graphene oxide nanocomposite: Synthesized, characterization, and antibacterial activity.
    Wang H; Li J; Liang H; Huang X; Meng N; Zhou N
    Colloids Surf B Biointerfaces; 2023 Jan; 221():113009. PubMed ID: 36399904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery.
    Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N
    Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
    Wu J; Shen Q; Fang L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion complex of lurasidone hydrochloride with Sulfobutylether-β-cyclodextrin has enhanced oral bioavailability and no food effect.
    Wang J; Huang B; Dai J; Chen G; Ren L
    Am J Transl Res; 2022; 14(3):1495-1506. PubMed ID: 35422944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of sulfobutylether β-cyclodextrin-silica hybrid monolithic column, and its application to capillary electrochromatography of chiral compounds.
    Zhou L; Liu B; Guan J; Jiang Z; Guo X
    J Chromatogr A; 2020 Jun; 1620():460932. PubMed ID: 32029266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
    Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of sarpogrelate external preparation for intractable pain control. I. Pre-formulation study on application of modified beta-cyclodextrins.
    Hanawa K; Hanawa T; Tsuchiya C; Higashi K; Suzuki M; Moribe K; Yamamoto K; Oguchi T
    Chem Pharm Bull (Tokyo); 2010 Jan; 58(1):45-50. PubMed ID: 20045965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
    Fukuda M; Miller DA; Peppas NA; McGinity JW
    Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sulfobutylether- and sulfated-beta-cyclodextrins as additives for the chiral separation of basic spirobenzopyrans by capillary electrophoresis.
    Morin P; Dreux M; Usse S; Viaud MC; Guillaumet G
    Electrophoresis; 1999 Sep; 20(13):2630-7. PubMed ID: 10532328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 33. Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes.
    Parvathaneni V; Elbatanony RS; Goyal M; Chavan T; Vega N; Kolluru S; Muth A; Gupta V; Kunda NK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A luminescence study of the interaction of sulfobutylether-β-cyclodextrin with rutin.
    Wu M; Song Z; Zhang J
    Drug Metab Lett; 2011 Dec; 5(4):259-66. PubMed ID: 22292472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
    Rajewski RA; Stella VJ
    J Pharm Sci; 1996 Nov; 85(11):1142-69. PubMed ID: 8923319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes.
    Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B
    Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.
    Sotthivirat S; Haslam JL; Stella VJ
    Int J Pharm; 2007 Feb; 330(1-2):73-81. PubMed ID: 17045435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
    Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.